Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | HCID 67429973 | HCID 67429973 | — |
| Solvent | Diethyl Ether | HCID 3283 | — |
| Solvent | 1,4-Dioxane | HCID 31275 | — |
| Product | HCID 67429972 | HCID 67429972 | 179.8% |
Reaction Steps
100 mg of N-[(1S,2R)-1-benzyl-2-hydroxy-3-{[3-(trifluoromethyl)benzyl]-amino}propyl]-6-chloro-4-oxo-3-(1-propylbutyl)-3,4-dihydroquinazoline-8-carboxamide are dissolved in 1.2 cm3 of ethyl ether at a temperature close to 20° C. 0.3 cm3 of a 4M solution of hydrochloric acid in dioxane is added, while stirring and under argon, at a temperature of 5° C. The reaction mixture precipitates, then the precipitate is dissolved. 5 cm3 of ethyl ether are added. The solution is concentrated under reduced pressure (5 kPa). 95 mg of N-[(1S,2R)-1-benzyl-2-hydroxy-3-{[3-(trifluoromethyl)benzyl]amino}propyl]-6-chloro-4-oxo-3-(1-propylbutyl)-3,4-dihydroquinazoline-8-carboxamide hydrochloride (1:1) are obtained in the form of an amorphous beige.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08030320B2 |
|---|
| Source dataset | uspto-grants-2011_10 |
|---|
| ORD ID | ord-9d286766e46b4cefbdeadb47ed0f24dd |
|---|
| Source note | uspto-grants-2011_10 |
|---|